Company Profile
TherapeuticsMD Stock Price, News & Analysis
- Ticker:
- TXMD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, TherapeuticsMD is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
2.00 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
23.15M USD
Market cap
Why the stock is moving
TXMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
TherapeuticsMD is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, TherapeuticsMD is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
TherapeuticsMD follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, TherapeuticsMD sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
TherapeuticsMD Announces First Quarter 2026 Financial Results
Source: TherapeuticsMD
- 02
TherapeuticsMD Announces Third Quarter 2023 Financial Results
Source: TherapeuticsMD
- 03
TherapeuticsMD Announces Full Year 2023 Financial Results
Source: TherapeuticsMD
- 04
TherapeuticsMD Announces First Quarter 2024 Financial Results
Source: TherapeuticsMD
- 05
TherapeuticsMD Announces Second Quarter 2024 Financial Results
Source: TherapeuticsMD
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of TherapeuticsMD (TXMD)?
TherapeuticsMD (TXMD) most recently closed at 2.00 USD, a 0.00% move versus the previous session.
What is the market cap of TherapeuticsMD (TXMD)?
TherapeuticsMD currently has a market capitalization of 23.15M USD on BioPharmSignal.
What does TherapeuticsMD do?
TherapeuticsMD is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TXMD stock listed?
TherapeuticsMD (TXMD) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, TherapeuticsMD is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is TherapeuticsMD?
TherapeuticsMD is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is TherapeuticsMD targeting with TherapeuticsMD?
TherapeuticsMD is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.